List of Oncology Medication For

Bile Duct Cancer

Bile duct cancer is a rare disease in which malignant (cancer) cells form in the bile ducts. Bile duct cancer is also called cholangiocarcinoma.
A network of tubes, called ducts, connects the liver, gallbladder, and small intestine. This network begins in the liver where many small ducts collect bile (a fluid made by the liver to break down fats during digestion). The small ducts come together to form the right and left hepatic ducts, which lead out of the liver. Types of bile duct cancer 1. Intrahepatic bile duct cancer and 2. Extrahepatic bile duct cancer.

If Bile duct cancer medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Capecitabine tablets

Colon, Bile Duct Cancer, Breast Cancer, Esophageal, Pancreatic, Stomach

Capecitabine tablets
for oral use Initial U.S. Approval: 1998

capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: • Adjuv ant Colon Cancer –Patients with Dukes’ C colon cancer • Metastatic Colorectal Cancer –First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred • Metastatic Breast Cancer –In combination with docetaxel after failure of prior anthracyclinecontaining therapy –As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen

Facts about capecitabine tablets

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): capecitabine tablets
Dosage Forms And Strengths: Tablets: 150 mg and 500 mgTablets: 150 mg and 500 mg
Company: Genentech
Current indications: Breast cancer, Colorectal cancer, Pancreatic adenocarcinoma, Stomach (gastric) cancer, esophageal cancer, or gastroesophageal junction cancer in adults, Stomach (gastric) cancer or gastroesophageal junction cancer in adults.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import capecitabine tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

CISPLATIN for injection

Ovarian, Bile Duct Cancer, Bladder

CISPLATIN for injection
for intravenous use Initial U.S. Approval: 1978

Cisplatin for injection is a platinum-based drug indicated for the treatment of: • Advanced testicular cancer • Advanced ovarian cancer • Advanced bladder cancer

Facts about CISPLATIN for injection

Approval Date: 1978
Proprietary Name: On Request
Active Ingredient(s): CISPLATIN for injection
Dosage Forms And Strengths: Lyophilized powder: Single-dose vials containing 50 mg
Company: WG Critical Care
Current indications: • Advanced testicular cancer • Advanced ovarian cancer • Advanced bladder cancer
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import CISPLATIN for injection” based on the information you provide.

FLUOROURACIL injection

Colon, Bile Duct Cancer, Breast Cancer, Esophageal, Gastrointestinal, Pancreatic

FLUOROURACIL injection
for intravenous use Initial U.S. Approval: 1962

Fluorouracil is a nucleoside metabolic inhibitor indicated for the treatment of patients with • Adenocarcinoma of the Colon and Rectum
• Adenocarcinoma of the Breast • Gastric Adenocarcinoma • Pancreatic Adenocarcinoma

Facts about FLUOROURACIL injection

Approval Date: 1962
Proprietary Name: On Request
Active Ingredient(s): FLUOROURACIL injection
Dosage Forms And Strengths: Injection: 2.5 g in a 50 mL vial in a pharmacy bulk package
Company: Spectrum Pharmaceuticals, Inc.
Current indications: • Adenocarcinoma of the Colon and Rectum • Adenocarcinoma of the Breast • Gastric Adenocarcinoma • Pancreatic Adenocarcinoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import FLUOROURACIL injection” based on the information you provide.

Futibatinib Tablets

Gastrointestinal, Bile Duct Cancer

Futibatinib Tablets
for oral use Initial U.S. Approval: YYYY

Lytgobi (futibatinib) is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. This medicine was approved by the FDA in the USA on 22 September 2022.

Facts about futibatinib) tablets

Approval Date: 9/30/2022
Proprietary Name: Lytgobi
Active Ingredient(s): futibatinib
DISEASE INDICATIONS-Bile Duct Cancer
MANUFACTURER-Taiho Pharmaceuticals
USAGE-Tablets: 4 mg
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “futibatinib) tablets” based on the information you provide.

Gemcitabine for injection

Ovarian, Bile Duct Cancer, Breast Cancer, Lung Cancer, Pancreatic

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

Infigratinib Capsules

Gastrointestinal, Bile Duct Cancer

Generic Name: Infigratinib Capsules
Infigratinib Capsules is used to treat a certain type of cholangiocarcinoma (bile duct cancer).

Truseltiq (infigratinib) is a prescription medicine used to treat previously-treated locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about infigratinib capsules

Disease Indications-Bile Duct Cancer
Manufacturer-QED Therapeutics
Usage-Oral Capsules: 25 mg and 100 mg
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “infigratinib capsules” based on the information you provide.

Ivosidenib Tablets

Leukemia, Bile Duct Cancer, Gastrointestinal

Ivosidenib tablets
for oral use Initial U.S. Approval: 2018

Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have: Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or Locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about ivosidenib tablets

Disease Indications-Leukemia, Bile Duct Cancer
Manufacturer-Servier Pharmaceuticals
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ivosidenib Tablets” based on the information you provide.

LYTGOBI (futibatinib) tablets

Bile Duct Cancer

Generic Name: futibatinib Brand Name: LYTGOBI
LYTGOBI (futibatinib) is used to treat adults with bile duct cancer (intrahepatic cholangiocarcinoma).

LYTGOBI is a prescription medicine that is used to treat adults with bile duct cancer (intrahepatic cholangiocarcinoma) that has spread or cannot be removed by surgery, who have already received a previous treatment, and whose tumor has a certain type of abnormal “FGFR2” gene.

Brand Name:	LYTGOBI
Generic Name:	futibatinib
Strength:	Tablets: 4 mg
Manufacturer:	Taiho Oncology Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “LYTGOBI (futibatinib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for LYTGOBI (futibatinib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

TIBSOVO (ivosidenib Tablets)

Leukemia, Bile Duct Cancer

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

TIBSOVO is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. If you have any questions about your illness, talk to your doctor.

Brand Name:	TIBSOVO
Generic Name:	ivosidenib
Strength:	Tablets: 250 mg (3
Manufacturer:	Servier Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import TIBSOVO (ivosidenib Tablets) ” based on the information you provide.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Bile Duct Cancer

Capecitabine tablets for oral use Initial U.S. Approval: 1998

Facts about capecitabine tablets

Access the best support services globally

CISPLATIN for injection for intravenous use Initial U.S. Approval: 1978

Facts about CISPLATIN for injection

Access the best support services globally

FLUOROURACIL injection for intravenous use Initial U.S. Approval: 1962

Facts about FLUOROURACIL injection

Access the best support services globally

Futibatinib Tablets for oral use Initial U.S. Approval: YYYY

Facts about futibatinib) tablets

Access the best support services globally

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

Generic Name: Infigratinib Capsules Infigratinib Capsules is used to treat a certain type of cholangiocarcinoma (bile duct cancer).

Facts about infigratinib capsules

Access the best support services globally

Ivosidenib tablets for oral use Initial U.S. Approval: 2018

Facts about ivosidenib tablets

Access the best support services globally

Generic Name: futibatinib Brand Name: LYTGOBI LYTGOBI (futibatinib) is used to treat adults with bile duct cancer (intrahepatic cholangiocarcinoma).

Generic Name: ivosidenib Brand Name: TIBSOVO TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

Access Patient Name Basis Treatment

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Capecitabine tablets
for oral use Initial U.S. Approval: 1998

CISPLATIN for injection
for intravenous use Initial U.S. Approval: 1978

FLUOROURACIL injection
for intravenous use Initial U.S. Approval: 1962

Futibatinib Tablets
for oral use Initial U.S. Approval: YYYY

Generic Name: Infigratinib Capsules
Infigratinib Capsules is used to treat a certain type of cholangiocarcinoma (bile duct cancer).

Ivosidenib tablets
for oral use Initial U.S. Approval: 2018

Generic Name: futibatinib Brand Name: LYTGOBI
LYTGOBI (futibatinib) is used to treat adults with bile duct cancer (intrahepatic cholangiocarcinoma).

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).